IRIS
BAUCKNEHT, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.767
Totale 8.767
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.767
Totale 8.767
Salva come PNG Salva come JPEG
Città #
Genova 4.619
Genoa 1.619
Rapallo 1.470
Vado Ligure 1.019
Bordighera 40
Totale 8.767
Salva come PNG Salva come JPEG
Nome #
18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: Inverse correlation between calcification density and mineral metabolic activity 169
The vulnerable coronary plaque: update on imaging technologies. 167
Amyloid positron emission tomography and cognitive reserve. 145
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 139
Cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by Koivuniemi et al. 138
Cardiovascular effects of antimuscarinic agents in overactive bladder 138
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 137
Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study 136
A Mathematical Model for the Vessel Recruitment in Coronary Microcirculation In the Absence of Active Autoregulation 134
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 133
Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CT 132
Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severity. 129
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 123
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 122
Assessment of skeletal tumor load in metastasized castration-resistant prostate cancer patients: A review of available methods and an overview on future perspectives 122
Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational18F-FDG PET/CT observation 118
A new frontier for amyloid PET imaging: multiple sclerosis 117
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 113
Spinocerebellar ataxia 17: full phenotype in a 41 CAG/CAA repeats carrier. 113
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 113
Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles 110
G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells 110
Early identification of MCI converting to AD: a FDG PET study 106
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 105
Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress 104
New tracers and new perspectives for molecular imaging in Lewy body diseases 103
Obligatory role of endoplasmic reticulum in brain FDG uptake 101
FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study 100
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis 99
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 96
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence 96
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 95
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline 95
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 95
Diagnostic value of ischemia severity at myocardial perfusion imaging in elderly persons with suspected coronary disease 94
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) 94
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder 94
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 92
A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility 91
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223 90
A kinetics-based approach to amyloid PET semi-quantification 89
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 88
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 88
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: A Possible Role for RANK/RANKL Pathway 88
Metabolic patterns across core features in dementia with lewy bodies 87
Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images 87
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 85
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 85
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 81
Amyloid PET imaging: Standardization and integration with other Alzheimer's disease biomarkers 80
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 80
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab 80
REPLY: Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: Are There Unsuspected Confounders? 79
Metabolic correlates of dopaminergic loss in dementia with lewy bodies 79
Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography? 77
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 77
18F-Fluorodeoxyglucose Imaging of Inflammation: Ready to Represent a Standard in Diagnosing Endocarditis? 73
Neuroimaging Findings in Mild Cognitive Impairment 73
In vitro Evidence of Abnormal Glutamate to Glutamine Conversion in Astrocytes harvested from a Mouse Model of Amyotrophic Lateral Sclerosis: a potential Experimental Application of N-13-ammonia 72
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 70
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 68
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 68
18f-fluorodeoxyglucose positron emission tomography tracks the heterogeneous brain susceptibility to the hyperglycemia-related redox stress 68
Probing the Role of a Regional Quantitative Assessment of Amyloid PET 66
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project 66
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 65
Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study 64
Doxorubicin effect on myocardial metabolism: a translational 18F-FDG PET/CT approach 64
Baseline 18F-Fluoride PET-derived parameters predict modification of toxicity-and response-related blood biomarkers in prostate cancer patients treated with 223Ra-Dichloride: preliminary results 63
Prognostic power of the human psoas muscles FDG metabolism in amyotrophic lateral sclerosis 63
The Elusive Link Between Cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in Diabetes 62
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 56
Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection 56
Mitochondrial Generated Redox Stress Differently Affects the Endoplasmic Reticulum of Circulating Lymphocytes and Monocytes in Treatment‐Naïve Hodgkin’s Lymphoma 55
Infarto miocardico acuto in gravidanza 54
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis 54
18F-FDG-PET correlates of aging and disease course in ALS as revealed by distinct PVC approaches 51
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica 51
Non-invasive measurement of coronary flow reserve: uniqueness of radionuclide methods and alternative techniques 50
18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at? 50
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 48
Myocardial metabolic response predicts chemotherapy curative potential on hodgkin lymphoma: A proof-of-concept study 48
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study) 48
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 48
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 47
The Role of Endoplasmic Reticulum in the Differential Endurance against Redox Stress in Cortical and Spinal Astrocytes from the Newborn SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis 45
Two high-rate pentose-phosphate pathways in cancer cells 42
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 41
Imaging biomarkers in Alzheimer's disease: Added value in the clinical setting 40
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 40
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223 40
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study 40
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 39
2-[18 F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study 39
Development of new theranostic probes targeting PSMA: computational strategies to explore ligand-target interactions 35
The role of the immune metabolic prognostic index in patients with non-small cell lung cancer (Nsclc) in radiological progression during treatment with nivolumab 32
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives 32
Role of FDG PET/CT in the prognostic stratification and response assessment of castration-resistant prostate cancer treated with radium-223 dichloride 31
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management 30
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB) 29
Totale 8.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.271
article - articoli 40.296
book - libri 0
conference - conferenze 783
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.011
Totale 84.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.552 0 0 0 0 156 213 243 167 226 293 208 46
2020/20211.086 53 89 47 126 94 115 118 91 89 111 80 73
2021/20221.276 48 37 68 126 60 110 41 225 114 169 81 197
2022/20231.751 117 190 31 161 242 226 32 146 234 92 249 31
2023/20241.389 59 139 38 196 91 255 109 83 64 56 85 214
2024/20251.145 179 291 153 283 239 0 0 0 0 0 0 0
Totale 9.192